Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Human allogeneic bone marrow derived osteoblastic-like cells

EU orphan designation number: EU/3/13/1176   
Active ingredient: Human allogeneic bone marrow derived osteoblastic-like cells
Indication: Treatment of non-traumatic osteonecrosis
Sponsor: Bone Therapeutics SA
Rue Auguste Piccard 37, 6041 Gosselies, Belgique

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Orphan designation EMA/OD/070/13 (2013)5275 of 05/08/2013
13/04/2016 Change of name and/or address of sponsor